Selective control of gene expression by CDK9 in human cells

Journal of Cellular Physiology

Volumn 222, Issue 1, 2010, Pages 200-208

  Garriga, Judit ^a   Xie, Hongbo ^b   Obradovic, Zoran ^b   Graña, Xavier ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Information Science and Technology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9; FLAVOPIRIDOL;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE; CLUSTER ANALYSIS; CYCLIN-DEPENDENT KINASE 9; DNA PROBES; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PHOSPHOSERINE; REPRODUCIBILITY OF RESULTS; RNA POLYMERASE II; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 73949098573     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21938     Document Type: Article

References (51)

1. Ahn SH, Kim M, Buratowski S. 2004. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing. Mol Cell 13:67-76.
2. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM. 2001. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8:327-337.
3. Boehm AK, Saunders A, Werner J, Lis JT. 2003. Transcription factor and polymerase recruitment, modification, and movement on dhsp70 in vivo in the minutes following heat shock. Mol Cell Biol 23:7628-7637.
4. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
5. Bouchard C, Marquardt J, Bras A, Medema RH, Eilers M. 2004. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J 23:2830-2840.
6. Chao SH, Price DH. 2001. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem 276:31793-31799.
7. Chiu YL, Cao H, Jacque JM, Stevenson M, Rana TM. 2004. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol 78:2517-2529.
8. Cho EJ, Kobor MS, Kim M, Greenblatt J, Buratowski S. 2001. Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev 15:3319-3329.
9. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
10. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
11. Fabian MA, Biggs WH III, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M, Ford JM, Galvin M, Gerlach JL, Grotzfeld RM, Herrgard S, Insko DE, Insko MA, Lai AG, Lelias JM, Mehta SA, Milanov ZV, Velasco AM, Wodicka LM, Patel HK, Zarrinkar PP, Lockhart DJ. 2005. A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23:329-336.
12. Flores O, Lee G, Kessler J, Miller M, Schlief W, Tomassini J, Hazuda D. 1999. Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication. Proc Natl Acad Sci USA 96:7208-7213.
13. Garriga J, Graña X. 2004. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 337:15-23.
14. Garriga J, Mayol X, Graña X. 1996a. The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem J 319:293-298.
15. Garriga J, Peng J, Parreno M, Price DH, Henderson EE, Graña X. 1998. Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene 17:3093-3102.
16. Garriga J, Bhattacharya S, Calbo J, Marshall RM, Truongcao M, Haines DS, Grana X. 2003. CDK9is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol 23:5165-5173.
17. Giraud S, Hurlstone A, Avril S, Coqueret O. 2004. Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene. Oncogene 23:7391-7398.
18. Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM. 2006. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev 20:601-612.
19. Graña X, De Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J, Morgan DO, Giordano A. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci USA 91:3834-3838.
20. Hargreaves DC, Horng T, Medzhitov R. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138:129-145.
21. He N, Pezda AC, Zhou Q. 2006. Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation. Mol Cell Biol 26:7068-7076.
22. Hosack DA, Dennis G, Jr., Sherman BT, Lane HC, Lempicki RA. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70.
23. Hou T, Ray S, Brasier AR. 2007. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. J Biol Chem 282:37091-37102.
24. Keogh MC, Podolny V, Buratowski S. 2003. Bur1 kinase is required for efficient transcription elongation by RNA polymerase II. Mol Cell Biol 23:7005-7018.
25. Klebl B, Choidas A. 2006. CDK9/cyclin T1: A host cell target for antiretroviral therapy. Future Virol 1:317-330.
26. Kohoutek J, Li Q, Blazek D, Luo Z, Jiang H, Peterlin BM. 2009. Cyclin T2 is essential for mouse embryogenesis. Mol Cell Biol 29:3280-3285.
27. Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, Averett LM, Zhao H, Davis RE, Sathyamoorthy M, Wahl LM, Harris ED, Mikovits JA, Monks AP, Hollingshead MG, Sausville EA, Staudt LM. 2001. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol 2:RESEARCH0041.
28. Luecke HF, Yamamoto KR. 2005. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev 19:1116-1127.
29. Marshall RM, Graña X. 2006. Mechanisms controlling CDK9 activity. Front Biosci 11:2598-2613.
30. Marshall RM, Salerno D, Garriga J, Graña X. 2005. Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes. J Immunol 175:6402-6411.
31. Medlin J, Scurry A, Taylor A, Zhang F, Peterlin BM, Murphy S. 2005. P-TEFb is not an essential elongation factor for the intronless human U2 snRNA and histone H2b genes. EMBO J 24:4154-4165.
32. Murray S, Udupa R, Yao S, Hartzog G, Prelich G. 2001. Phosphorylation of the RNA polymerase II carboxy-terminal domain by the Bur1 cyclin-dependent kinase. Mol Cell Biol 21:4089-4096.
33. Ni Z, Schwartz BE, Werner J, Suarez JR, Lis JT. 2004. Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Mol Cell 13:55-65.
34. O'Keeffe B, Fong Y, Chen D, Zhou S, Zhou Q. 2000. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 275:279-287.
35. Pei Y, Shuman S. 2003. Characterization of the Schizosaccharomyces pombe Cdk9/Pch1 protein kinase: Spt5 phosphorylation, autophosphorylation, and mutational analysis. J Biol Chem 278:43346-43356.
36. Peng J, Marshall NF, Price DH. 1998a. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J Biol Chem 273:13855-13860.
37. Peng J, Zhu Y, Milton JT, Price DH. 1998b. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 12:755-762.
38. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23:297-305.
39. Salerno D, Hasham MG, Marshall R, Garriga J, Tsygankov AY, Grana X. 2007. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Gene 405:65-78.
40. Sano M, Schneider MD. 2003. Cyclins that don't cycle - Cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle 2:99-104.
41. Scibetta AG, Copier J, Barrett A, Chaplin T, Taylor-Papadimitriou J. 2005. Gene expression changes induced by a recombinant E1-/E3-adenovirus type 5 vector in human mammary epithelial cells. Intervirology 48:350-361.
42. Sedlacek HH. 2001. Mechanisms of action of flavopiridol. Crit Rev Oncol Hematol 38:139-170.
43. Shim EY, Walker AK, Shi Y, Blackwell TK. 2002. CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes Dev 16:2135-2146.
44. Tian Y, Ke S, Chen M, Sheng T. 2003. Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter. J Biol Chem 278:44041-44048.
45. Viladevall L, St Amour CV, Rosebrock A, Schneider S, Zhang C, Allen JJ, Shokat KM, Schwer B, Leatherwood JK, Fisher RP. 2009. TFIIH and P-TEFb coordinate transcription with capping enzyme recruitment at specific genes in fission yeast. Mol Cell 33:738-751.
46. Wang S, Fischer PM. 2008. Cyclin-dependent kinase 9: A key transcriptional regulator and potential drug target in oncology, virology and cardiology. Trends Pharmacol Sci 29:302-313.
47. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andres V. 1997. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Cir Res 80:418-426.
48. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
49. Yang Z, He N, Zhou Q. 2008. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol Cell Biol 28:967-976.
50. Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, Brady JN. 2000. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol 20:5077-5086.
51. Zhou M, Deng L, Lacoste V, Park HU, Pumfery A, Kashanchi F, Brady JN, Kumar A. 2004. Coordination of transcription factor phosphorylation and histone methylation by the PTEFb kinase during human immunodeficiency virus type 1 transcription. J Virol 78:13522-13533.